Are you a medical professional looking for more information about certolizumab? Look no further! This ultimate guide has everything you need to know about this medication, including its uses, potential side effects, and who should avoid it. Whether you're new to prescribing certolizumab or simply want to refresh your knowledge on the topic, this comprehensive guide will provide you with all the necessary information. So sit back, relax, and let's dive into the world of certolizumab!
Certolizumab is a medication that belongs to a class of drugs called tumor necrosis factor (TNF) inhibitors. It works by blocking the action of TNF, which is a protein produced by the body's immune system and can cause inflammation.
This medication is used to treat autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease and ulcerative colitis.
Unlike other TNF inhibitors, certolizumab has been developed without any mouse or human-derived components. Instead, it consists solely of recombinant humanized antibodies fused with polyethylene glycol (PEG), which helps extend its half-life in the bloodstream.
As with any medication, certolizumab may cause side effects. Common side effects of certolizumab include redness, swelling, itching or pain at the injection site. These symptoms are usually mild and go away within a few days.
Other common side effects of certolizumab include headache and upper respiratory tract infections such as sinusitis or the common cold. These side effects may also be mild and typically resolve on their own.
Less common but potentially serious side effects of certolizumab include severe allergic reactions such as difficulty breathing, chest tightness or swelling of the face, lips or tongue.
Certolizumab is a medication that works by suppressing the activity of tumor necrosis factor-alpha (TNF-alpha), which is associated with various inflammatory and autoimmune diseases. However, not everyone can take certolizumab safely.
If you are allergic to certolizumab or any of its ingredients, you should not take this medication as it may cause an allergic reaction. Additionally, if you have a current or past history of tuberculosis (TB) or other infections such as hepatitis.
Pregnant women must avoid using certolizumab unless absolutely necessary because there is insufficient data on its safety in pregnancy. Similarly, breastfeeding mothers must also exercise caution when using this drug since it can pass into breast milk and potentially harm nursing infants.
Certolizumab is a highly effective medication for treating various autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and psoriatic arthritis. It works by blocking the action of TNF-alpha in the body which reduces inflammation and helps to alleviate symptoms.
While certolizumab can be an excellent option for patients who have not responded well to other treatments, it does come with some potentially serious side effects that need to be considered carefully before starting treatment.
1.
Is Laughter Good for Blood Glucose Control?
2.
Researchers find distinct cell receptors with the potential for new treatments.
3.
the contribution of cortactin to the development of cancer.
4.
For patients with breast cancer receiving chemotherapy, exercise may help lessen the long-term side effects.
5.
Decrease seen in in situ breast cancer since 2009
1.
AI-Powered Strategies for Precision and Improved Outcomes in Esophageal Cancer, a Global Health Crisis
2.
Elevating Hematology Oncology: Modern Approaches for Smarter Diagnosis and Treatment
3.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
4.
Unleashing the Power of Immune Triads: A Novel Approach to Cancer Immunotherapy
5.
Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
4.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
5.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation